GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » AI/ML Innovations Inc (FRA:42FB) » Definitions » YoY EBITDA Growth

AI/ML Innovations (FRA:42FB) YoY EBITDA Growth : 28.57% (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is AI/ML Innovations YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. AI/ML Innovations's YoY EBITDA Growth for the quarter that ended in Jan. 2024 was 28.57%.

AI/ML Innovations's EBITDA per Share for the three months ended in Jan. 2024 was €-0.01.


AI/ML Innovations YoY EBITDA Growth Historical Data

The historical data trend for AI/ML Innovations's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AI/ML Innovations YoY EBITDA Growth Chart

AI/ML Innovations Annual Data
Trend Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -163.64 -57.14 -18.18 -761.54 25.89

AI/ML Innovations Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Jul23 Oct23 Jan24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.07 60.00 64.29 58.33 28.57

AI/ML Innovations YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

AI/ML Innovations's YoY EBITDA Growth for the fiscal year that ended in Apr. 2022 is calculated as:

YoY EBITDA Growth (A: Apr. 2022 )
=(EBITDA per Share (A: Apr. 2022 )-EBITDA per Share (A: Apr. 2021 ))/ | EBITDA per Share (A: Apr. 2021 ) |
=(-0.083--0.112)/ | -0.112 |
=25.89 %

AI/ML Innovations's YoY EBITDA Growth for the quarter that ended in Jan. 2024 is calculated as:

YoY EBITDA Growth (Q: Jan. 2024 )
=(EBITDA per Share (Q: Jan. 2024 )-EBITDA per Share (Q: Oct. 2022 )) / | EBITDA per Share (Q: Oct. 2022 )) |
=(-0.005--0.007)/ | -0.007 |
=28.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AI/ML Innovations YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of AI/ML Innovations's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


AI/ML Innovations (FRA:42FB) Business Description

Traded in Other Exchanges
Address
645 Fort Street, Suite 203, Victoria, BC, CAN, V8W 1G2
AI/ML Innovations Inc has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence and machine learning, with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. The company has strategic partnerships with Health Gauge, Tech2Health and other planned accretive investments.

AI/ML Innovations (FRA:42FB) Headlines

No Headlines